|
LCTX Lineage Cell Therapeutics Inc 876343 |
| Balance Sheet |
|
Current Assets
|
$52,970,000.00 |
|
Assets
|
$106,220,000.00 |
|
Current Liabilities
|
$8,016,000.00 |
|
Liabilities
|
$46,422,000.00 |
|
Equity
|
$60,916,000.00 |
|
Shares Out
|
252907464.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-15,322,000.00 |
|
Investing Cash Flow
|
$1,634,000.00 |
| Market Analysis |
Market Cap
|
$273,140,061.12 |
|
Price
|
$1.08 |
|
BVPS
|
0.24 |
|
PB
|
4.50 |
|
EPS
|
0.01 |
|
PS
|
63.88 |
|
FCF
|
$-15,485,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:34 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.28 |
|
|
2026-05-12 |
-0.03 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.13 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.13 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LCTX documents filed with the SEC.
LCTX Filings
Clear
